摘要
目的观察依达拉奉联合复方麝香注射液对脑干出血患者预后的影响。方法选择2006年1月-2009年10月在河北省唐山市丰润区人民医院住院的原发性脑干出血患者60例随机分为复方麝香注射液组(A组)与依达拉奉联合复方麝香注射液组(B组),比较治疗前、治疗后14d及2个月时的美国国立卫生研究院卒中量表评分(NHISS),治疗前、治疗后2个月时barthel(BI)指数。结果 B组NHISS及BI评分幅度变化大于A组。结论依达拉奉联合复方麝香注射液治疗脑干出血能显著改善患者的预后。
Objective：To evaluate the efficacy of edaravone combined with compound muskiness injection on brainstem hemorrhage.Methods：60 patients from January 2006 to October 2009 with brainstem hemorrhage were randomly divided into the A group with compound muskiness injection and the B group with edaravone combined with compound muskiness injection.These indices were comapred in the 2 groups.The NHISS was evaluated before the treatment and the 14th day and the 2nd month after treatment.The BI socre and the clincal effect were noted before the treatment and 2 months after treatment.Results：The variable degrees of the NHISS and BI in the B group were larger than those in the A group.Conclusion：Edaravone combined with compound muskiness injection can improve the prognosis of brainstem hemorrhage.
出处
《中国中医急症》
2011年第2期189-190,共2页
Journal of Emergency in Traditional Chinese Medicine
关键词
脑干出血
复方麝香注射液
依达拉奉
Brainstem hemorrhage
Compound muskiness injection
Edaravone
